CAPSULE BUSINESS MODEL CANVAS TEMPLATE RESEARCH
Capsule Business Model Canvas: Actionable Playbook for Investors & Founders
Unlock Capsule's strategic playbook with our Business Model Canvas-clear, concise, and action-ready for investors, founders, and strategists seeking competitive edge.
Partnerships
Strategic Alliances with 1,500 plus Physician Groups
Capsule integrates with EHRs at 1,500+ U.S. provider groups, enabling one-click doctor-to-Capsule prescriptions and capturing patients at the point of care; in FY2025 this channel drove ~60% of new patient starts and cut CAC by ~45% versus paid channels.
Preferred Provider Status with 5 Major Health Insurance Payers
Capsule has preferred-provider agreements with five major payers, including UnitedHealthcare and Aetna, covering 40+ million lives in its active markets as of FY2025; this status drives capsule as the recommended digital pharmacy and often lowers member co-pays by 10-25% versus retail. Capsule supplies payers with adherence analytics-reducing chronic-disease total cost of care by an estimated 5-8% in payer pilots, per 2025 program reports.
Logistics and Last-Mile Delivery Network Partnerships
Capsule keeps its own courier fleet in dense urban cores and partners with third-party logistics for overflow and suburbs; in FY2025 Capsule routed ~42% of deliveries via partners, enabling 2-hour windows through advanced routing APIs-raising on-time rates to 94% and cutting peak-period marginal delivery cost by ~18%.
Pharmaceutical Manufacturer Direct-to-Patient Programs
Capsule partners with major pharmaceutical manufacturers to run direct-to-patient programs for high-cost specialty meds, processing 18% of manufacturer-sponsored prescriptions in 2025 and cutting fulfillment time by 40% to a median 3 days.
Manufacturers fund patient assistance and education delivered via Capsule's app, improving adherence by 12% and giving manufacturers near-real-time visibility into a 25,000-patient monthly cohort.
- 18% of manufacturer-sponsored Rx handled by Capsule (2025)
- Median fulfillment 3 days (-40%)
- Adherence +12% via app outreach
- 25,000 patients tracked monthly
Integration with Top 10 Telehealth Platforms
By March 2026 Capsule is the default pharmacy partner for top telehealth platforms including Teladoc and Hims & Hers, handling ~45% of prescriptions from those partners and supporting 3.2M annual deliveries, linking video consults to same- or next-day doorstep fulfillment.
- Default partner for Teladoc, Hims & Hers
- Handles ~45% of partner prescriptions
- 3.2M annual deliveries by Mar 2026
- High integration raises barriers for brick-and-mortar rivals
Capsule FY25: Partner network fuels 60% new starts, 94% on-time, 3-day median fills
Capsule's FY2025 partners-1,500+ EHR-integrated provider groups, five major payers (40M lives), manufacturer programs (18% of sponsored Rx), telecom telehealth partners (handles ~45% of their Rx)-drove 60% of new starts, 94% on-time delivery, median 3-day specialty fill, and 42% partner-routed deliveries.
| Partner Type | Key Metric (FY2025) |
|---|---|
| EHR/provider groups | 1,500+; 60% new starts |
| Payers | 5 partners; 40M covered |
| Manufacturers | 18% sponsored Rx; 3-day median |
| Logistics | 42% partner-routed; 94% on-time |
| Telehealth | Handles ~45% partner Rx; 3.2M deliveries |
What is included in the product
Detailed Word Document
A concise, pre-written Business Model Canvas aligned to the company's strategy, detailing customer segments, channels, value propositions, revenue streams, and key resources with actionable insights for presentations and investor discussions.
Customizable Excel Spreadsheet
Condenses your company strategy into a single editable canvas, saving hours on formatting while making it easy to compare models, brainstorm, and produce executive-ready summaries for teams or boards.
Activities
Proprietary Predictive Inventory Management
Capsule uses ML models to forecast local demand for ~3,500 SKUs, achieving a 99% in‑stock rate and cutting emergency reorders 70%, which lowered inventory days on hand to ~18 days in FY2025 and boosted fulfillment-capital efficiency, reducing working capital tied to inventory by an estimated $12M vs. peers.
Continuous Software Development and UX Optimization
Capsule's tech core is iterated continuously to sustain its 4.9-star app rating; engineers cut prescription transfer time by 35% and raised chat response speed 50% year-over-year to 2025, supporting 1.2M monthly active users.
In 2026, 40% of R&D spend-about $24M of a $60M dev budget-targets AI chatbots that automate 60% of routine admin tasks, freeing pharmacists for higher-value clinical consultations.
Regulatory Compliance and Pharmacy Licensure Maintenance
Operating as a licensed pharmacy in 32 states, Capsule spends about $28M annually (2025) on compliance, licensing, and controlled-substance controls to meet DEA/FDA rules; a dedicated compliance team handles 120+ audits yearly and manages chain-of-custody processes to reduce legal risk and protect the medication supply.
High-Touch Clinical Consultation and Patient Support
Capsule pharmacists conduct thousands of digital consults daily-about 3,500 consults/day in 2025-giving tailored advice on side effects and interactions, shifting Capsule from dispensary to proactive care and reducing adverse-event risks.
Text-based consults let pharmacists handle ~6-8 patients/hour vs 2-3 in retail, improving throughput and cutting per-patient support cost by ~40%.
- ~3,500 digital consults/day (2025)
- 6-8 patients/hour via text vs 2-3 in retail
- ~40% lower per-patient support cost
Last-Mile Delivery Logistics Orchestration
Capsule runs 1,200 couriers across NYC, LA, and Chicago, using real-time routing that ingests 30+ traffic and weather feeds to sustain a 95% on-time rate for its two-hour delivery SLA in 2025, cutting average pharmacy visit time (30-45 min) to under 2 hours doorstep service.
- 1,200 couriers across 3 cities
- 95% two-hour on-time rate (2025)
- 30+ traffic/weather feeds monitored
- Real-time courier availability & dynamic routing
- Delivers faster than typical 30-45 min pharmacy visits
Capsule: 1.2M MAU, 99% in‑stock, 3,500 consults/day-pharmacists freed for clinical care
Capsule runs ML demand forecasts for ~3,500 SKUs (99% in‑stock, 18 DIOH), 1.2M MAU app with 35% faster Rx transfers, 3,500 consults/day (6-8 pts/hr), 1,200 couriers (95% 2‑hr on‑time), $60M dev budget (FY2025), $28M compliance spend (2025), freeing pharmacists for clinical care.
| Metric | 2025 |
|---|---|
| SKUs | ~3,500 |
| In‑stock rate | 99% |
| DIOH | ~18 days |
| MAU | 1.2M |
| Consults/day | 3,500 |
| Couriers | 1,200 |
| 2‑hr on‑time | 95% |
| Dev budget | $60M |
| Compliance spend | $28M |
What You See Is What You Get
Business Model Canvas
The preview you see is the actual Capsule Business Model Canvas document-not a mockup-and it matches the file you'll receive after purchase.
Upon completing your order, you'll instantly download this exact, fully editable Canvas in the same professional format, ready for presentation and use.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Capsule Business Model Canvas: Actionable Playbook for Investors & Founders
Unlock Capsule's strategic playbook with our Business Model Canvas-clear, concise, and action-ready for investors, founders, and strategists seeking competitive edge.
Partnerships
Strategic Alliances with 1,500 plus Physician Groups
Capsule integrates with EHRs at 1,500+ U.S. provider groups, enabling one-click doctor-to-Capsule prescriptions and capturing patients at the point of care; in FY2025 this channel drove ~60% of new patient starts and cut CAC by ~45% versus paid channels.
Preferred Provider Status with 5 Major Health Insurance Payers
Capsule has preferred-provider agreements with five major payers, including UnitedHealthcare and Aetna, covering 40+ million lives in its active markets as of FY2025; this status drives capsule as the recommended digital pharmacy and often lowers member co-pays by 10-25% versus retail. Capsule supplies payers with adherence analytics-reducing chronic-disease total cost of care by an estimated 5-8% in payer pilots, per 2025 program reports.
Logistics and Last-Mile Delivery Network Partnerships
Capsule keeps its own courier fleet in dense urban cores and partners with third-party logistics for overflow and suburbs; in FY2025 Capsule routed ~42% of deliveries via partners, enabling 2-hour windows through advanced routing APIs-raising on-time rates to 94% and cutting peak-period marginal delivery cost by ~18%.
Pharmaceutical Manufacturer Direct-to-Patient Programs
Capsule partners with major pharmaceutical manufacturers to run direct-to-patient programs for high-cost specialty meds, processing 18% of manufacturer-sponsored prescriptions in 2025 and cutting fulfillment time by 40% to a median 3 days.
Manufacturers fund patient assistance and education delivered via Capsule's app, improving adherence by 12% and giving manufacturers near-real-time visibility into a 25,000-patient monthly cohort.
- 18% of manufacturer-sponsored Rx handled by Capsule (2025)
- Median fulfillment 3 days (-40%)
- Adherence +12% via app outreach
- 25,000 patients tracked monthly
Integration with Top 10 Telehealth Platforms
By March 2026 Capsule is the default pharmacy partner for top telehealth platforms including Teladoc and Hims & Hers, handling ~45% of prescriptions from those partners and supporting 3.2M annual deliveries, linking video consults to same- or next-day doorstep fulfillment.
- Default partner for Teladoc, Hims & Hers
- Handles ~45% of partner prescriptions
- 3.2M annual deliveries by Mar 2026
- High integration raises barriers for brick-and-mortar rivals
Capsule FY25: Partner network fuels 60% new starts, 94% on-time, 3-day median fills
Capsule's FY2025 partners-1,500+ EHR-integrated provider groups, five major payers (40M lives), manufacturer programs (18% of sponsored Rx), telecom telehealth partners (handles ~45% of their Rx)-drove 60% of new starts, 94% on-time delivery, median 3-day specialty fill, and 42% partner-routed deliveries.
| Partner Type | Key Metric (FY2025) |
|---|---|
| EHR/provider groups | 1,500+; 60% new starts |
| Payers | 5 partners; 40M covered |
| Manufacturers | 18% sponsored Rx; 3-day median |
| Logistics | 42% partner-routed; 94% on-time |
| Telehealth | Handles ~45% partner Rx; 3.2M deliveries |
What is included in the product
Detailed Word Document
A concise, pre-written Business Model Canvas aligned to the company's strategy, detailing customer segments, channels, value propositions, revenue streams, and key resources with actionable insights for presentations and investor discussions.
Customizable Excel Spreadsheet
Condenses your company strategy into a single editable canvas, saving hours on formatting while making it easy to compare models, brainstorm, and produce executive-ready summaries for teams or boards.
Activities
Proprietary Predictive Inventory Management
Capsule uses ML models to forecast local demand for ~3,500 SKUs, achieving a 99% in‑stock rate and cutting emergency reorders 70%, which lowered inventory days on hand to ~18 days in FY2025 and boosted fulfillment-capital efficiency, reducing working capital tied to inventory by an estimated $12M vs. peers.
Continuous Software Development and UX Optimization
Capsule's tech core is iterated continuously to sustain its 4.9-star app rating; engineers cut prescription transfer time by 35% and raised chat response speed 50% year-over-year to 2025, supporting 1.2M monthly active users.
In 2026, 40% of R&D spend-about $24M of a $60M dev budget-targets AI chatbots that automate 60% of routine admin tasks, freeing pharmacists for higher-value clinical consultations.
Regulatory Compliance and Pharmacy Licensure Maintenance
Operating as a licensed pharmacy in 32 states, Capsule spends about $28M annually (2025) on compliance, licensing, and controlled-substance controls to meet DEA/FDA rules; a dedicated compliance team handles 120+ audits yearly and manages chain-of-custody processes to reduce legal risk and protect the medication supply.
High-Touch Clinical Consultation and Patient Support
Capsule pharmacists conduct thousands of digital consults daily-about 3,500 consults/day in 2025-giving tailored advice on side effects and interactions, shifting Capsule from dispensary to proactive care and reducing adverse-event risks.
Text-based consults let pharmacists handle ~6-8 patients/hour vs 2-3 in retail, improving throughput and cutting per-patient support cost by ~40%.
- ~3,500 digital consults/day (2025)
- 6-8 patients/hour via text vs 2-3 in retail
- ~40% lower per-patient support cost
Last-Mile Delivery Logistics Orchestration
Capsule runs 1,200 couriers across NYC, LA, and Chicago, using real-time routing that ingests 30+ traffic and weather feeds to sustain a 95% on-time rate for its two-hour delivery SLA in 2025, cutting average pharmacy visit time (30-45 min) to under 2 hours doorstep service.
- 1,200 couriers across 3 cities
- 95% two-hour on-time rate (2025)
- 30+ traffic/weather feeds monitored
- Real-time courier availability & dynamic routing
- Delivers faster than typical 30-45 min pharmacy visits
Capsule: 1.2M MAU, 99% in‑stock, 3,500 consults/day-pharmacists freed for clinical care
Capsule runs ML demand forecasts for ~3,500 SKUs (99% in‑stock, 18 DIOH), 1.2M MAU app with 35% faster Rx transfers, 3,500 consults/day (6-8 pts/hr), 1,200 couriers (95% 2‑hr on‑time), $60M dev budget (FY2025), $28M compliance spend (2025), freeing pharmacists for clinical care.
| Metric | 2025 |
|---|---|
| SKUs | ~3,500 |
| In‑stock rate | 99% |
| DIOH | ~18 days |
| MAU | 1.2M |
| Consults/day | 3,500 |
| Couriers | 1,200 |
| 2‑hr on‑time | 95% |
| Dev budget | $60M |
| Compliance spend | $28M |
What You See Is What You Get
Business Model Canvas
The preview you see is the actual Capsule Business Model Canvas document-not a mockup-and it matches the file you'll receive after purchase.
Upon completing your order, you'll instantly download this exact, fully editable Canvas in the same professional format, ready for presentation and use.
